| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acknowledgement to Referees
|
|
|
|
|
12 |
p. 542-545
|
artikel
|
| 2 |
Acknowledgement to Referees
|
|
|
2017
|
|
12 |
p. 551-554
|
artikel
|
| 3 |
Acknowledgement to Referees
|
|
|
2015
|
|
12 |
p. 407-408
|
artikel
|
| 4 |
Acknowledgement to Referees
|
|
|
2016
|
|
12 |
p. 499-501
|
artikel
|
| 5 |
Acknowledgement to Referees
|
|
|
2018
|
|
12 |
p. 539-542
|
artikel
|
| 6 |
Acknowledgement to referees
|
|
|
2019
|
|
12 |
p. 579-582
|
artikel
|
| 7 |
Acknowledgement to referees
|
|
|
|
|
12 |
p. 553-556
|
artikel
|
| 8 |
Acknowledgement to referees
|
|
|
|
|
12 |
p. 535-538
|
artikel
|
| 9 |
Acknowledgement to Referees
|
|
|
|
|
12 |
p. 499-501
|
artikel
|
| 10 |
Acknowledgement to Referees
|
|
|
|
|
12 |
p. 448-451
|
artikel
|
| 11 |
Additional non-invasive options can be considered for erectile dysfunction when phosphodiesterase type 5 inhibitors fail
|
|
|
2018
|
|
12 |
p. 567-571
|
artikel
|
| 12 |
Adherence of patients with type 2 diabetes to refills and medications: a comparison between ‘telephone and collect’ and conventional counter services in a health clinic
|
Maruan, Khalidah
|
|
|
|
12 |
p. 590-597
|
artikel
|
| 13 |
Adjust therapy for restless legs syndrome if symptoms worsen, efficacy is lost or iatrogenic augmentation develops
|
|
|
2015
|
|
12 |
p. 433-436
|
artikel
|
| 14 |
Adverse events and monitoring requirements associated with monoclonal antibody therapy in patients with multiple sclerosis
|
Fragoso, Yara Dadalti
|
|
|
|
12 |
p. 627-634
|
artikel
|
| 15 |
Adverse events and monitoring requirements associated with monoclonal antibody therapy in patients with multiple sclerosis
|
Fragoso, Yara Dadalti
|
|
2019
|
|
12 |
p. 627-634
|
artikel
|
| 16 |
Anakinra in Still’s disease: a profile of its use
|
Lyseng-Williamson, Katherine A.
|
|
2018
|
|
12 |
p. 543-553
|
artikel
|
| 17 |
A new complication of imatinib: a case report
|
Chauhan, Sushila
|
|
2018
|
|
12 |
p. 590-592
|
artikel
|
| 18 |
Anticonvulsant-induced cutaneous reactions present a challenge
|
|
|
2000
|
|
12 |
p. 11-14
|
artikel
|
| 19 |
Are therapies for the treatment and prevention of stroke cost saving?
|
|
|
2000
|
|
12 |
p. 14-16
|
artikel
|
| 20 |
Assess the evidence and prepare plan of action prior to intentional rechallenge with drugs suspected of causing an adverse reaction
|
|
|
2013
|
|
12 |
p. 395-397
|
artikel
|
| 21 |
Association between variants of COQ2 and TNF-α genes and statin-induced toxicities in Bangladeshi hyperlipidemic patients
|
Chowdhury, Fabliha Ahmed
|
|
2019
|
|
12 |
p. 621-626
|
artikel
|
| 22 |
Azelastine hydrochloride/fluticasone propionate combined in a single nasal spray: a guide to its use in allergic rhinitis
|
Plosker, Greg L.
|
|
2015
|
|
12 |
p. 425-432
|
artikel
|
| 23 |
Ban on the use of cannabinoids in all sports during competition is supported by World Anti-Doping Agency criteria
|
|
|
2012
|
|
12 |
p. 24-26
|
artikel
|
| 24 |
Better than slim chances for orlistat and sibutramine to promote weight loss
|
|
|
2000
|
|
12 |
p. 1-6
|
artikel
|
| 25 |
Biyalirudin: a proven alternative to heparin for PTCA in patients with unstable angina
|
|
|
2002
|
|
12 |
p. 1-4
|
artikel
|
| 26 |
Both prevention and treatment are important when managing sickle cell disease
|
|
|
2014
|
|
12 |
p. 411-416
|
artikel
|
| 27 |
Cellulite: no clear evidence that any type of treatment is effective
|
|
|
2015
|
|
12 |
p. 437-440
|
artikel
|
| 28 |
Clinical and pharmacoeconomic aspects both play an important role in the treatment of ovarian cancer
|
|
|
2001
|
|
12 |
p. 12-15
|
artikel
|
| 29 |
Comprehensive surveillance of adverse drug reactions in hospital provides important data to inform the safe use of drug therapy
|
|
|
|
|
12 |
p. 14-16
|
artikel
|
| 30 |
Comprehensive surveillance of adverse drug reactions in hospital provides important data to inform the safe use of drug therapy
|
|
|
2002
|
|
12 |
p. 14-16
|
artikel
|
| 31 |
Consider drug pharmacokinetics when selecting the most suitable treatments for hepatitis C infection
|
,
|
|
|
|
12 |
p. 427-431
|
artikel
|
| 32 |
Consider drug pharmacokinetics when selecting the most suitable treatments for hepatitis C infection
|
|
|
2014
|
|
12 |
p. 427-431
|
artikel
|
| 33 |
Correction to: Amphetamine extended-release oral suspension (Adzenys ER™) and orally disintegrating tablets (Adzenys XR-ODT®) in attention-deficit hyperactivity disorder: a profile of their use
|
Lyseng-Williamson, Katherine A.
|
|
2018
|
|
12 |
p. 596
|
artikel
|
| 34 |
Correction to: Andexanet alfa in the treatment of acute major bleeding related to apixaban and rivaroxaban: a profile of its use in the USA
|
Heo, Young-A
|
|
2018
|
|
12 |
p. 593
|
artikel
|
| 35 |
Correction to: Burosumab in X-linked hypophosphatemia: a profile of its use in the USA
|
Lyseng-Williamson, Katherine A.
|
|
2018
|
|
12 |
p. 595
|
artikel
|
| 36 |
Correction to: Fostamatinib in chronic immune thrombocytopenia: a profile of its use in the USA
|
McKeage, Kate
|
|
2018
|
|
12 |
p. 594
|
artikel
|
| 37 |
Correction to: Insulin glargine/lixisenatide in type 2 diabetes: a profile of its use
|
Deeks, Emma
|
|
2019
|
|
12 |
p. 635
|
artikel
|
| 38 |
Correction to: Intranasal metoclopramide for acute and recurrent diabetic gastroparesis in adults
|
Singh-Franco, Devada
|
|
|
|
12 |
p. 607
|
artikel
|
| 39 |
Correction to: Lemborexant in insomnia disorder: a profile of its use
|
Blair, Hannah A.
|
|
|
|
12 |
p. 598-599
|
artikel
|
| 40 |
Correction to: RBX2660 (REBYOTA®) in preventing recurrence of Clostridioides difficile infection: a profile of its use in the USA
|
Blair, Hannah A.
|
|
|
|
12 |
p. 447
|
artikel
|
| 41 |
Current evidence supports the use of combination therapy in the management of benign prostatic hyperplasia
|
|
|
2012
|
|
12 |
p. 5-8
|
artikel
|
| 42 |
Distinguishing ‘adverse drug effects’ from ‘adverse drug reactions’: proposed definitions
|
|
|
2013
|
|
12 |
p. 392-394
|
artikel
|
| 43 |
Drug-induced skin pigmentation not rare, but difficult to diagnose
|
|
|
2002
|
|
12 |
p. 10-13
|
artikel
|
| 44 |
Drug interactions an increasing concern in dermatology
|
|
|
2000
|
|
12 |
p. 14-16
|
artikel
|
| 45 |
Drug treatment available for patients with severe restless legs syndrome
|
|
|
2000
|
|
12 |
p. 6-11
|
artikel
|
| 46 |
Early diagnosis and effective drug treatment essential for optimal management of acute viral infections of the CNS
|
,
|
|
|
|
12 |
p. 387-391
|
artikel
|
| 47 |
Early diagnosis and effective drug treatment essential for optimal management of acute viral infections of the CNS
|
|
|
2013
|
|
12 |
p. 387-391
|
artikel
|
| 48 |
Early targeted antibacterial therapy is essential when treating invasive group A streptococcal infection
|
|
|
|
|
12 |
p. 9-11
|
artikel
|
| 49 |
Early targeted antibacterial therapy is essential when treating invasive group A streptococcal infection
|
|
|
2012
|
|
12 |
p. 9-11
|
artikel
|
| 50 |
Educate patients with medication overuse headache, and intervene, when necessary
|
Fenton, Caroline
|
|
|
|
12 |
p. 573-578
|
artikel
|
| 51 |
Effective management of gout often requires multiple medications
|
|
|
2001
|
|
12 |
p. 8-12
|
artikel
|
| 52 |
Effective risk management is the key to maximising the benefits of self medication
|
|
|
2002
|
|
12 |
p. 22-25
|
artikel
|
| 53 |
Eribulin mesylate in previously treated patients with advanced liposarcoma: a guide to its use
|
Garnock-Jones, Karly P.
|
|
2016
|
|
12 |
p. 510-514
|
artikel
|
| 54 |
Erratum to: Lercanidipine/enalapril fixed-dose combination: a guide to its use in essential hypertension
|
|
|
2011
|
|
12 |
p. 26
|
artikel
|
| 55 |
Erratum to: Pazopanib in advanced renal cell carcinoma: a guide to its use in the EU
|
Lyseng-Williamson, Katherine A.
|
|
2015
|
|
12 |
p. 458
|
artikel
|
| 56 |
Evaluation of ophthalmic adverse drug reactions at a tertiary-care hospital
|
Patel, Jignesh
|
|
2015
|
|
12 |
p. 448-451
|
artikel
|
| 57 |
Exploring the utility of a spontaneous adverse drug reaction reporting system in identifying drug–drug interactions between antiretrovirals, antitubercular drugs, and cotrimoxazole: a case/non-case analysis
|
Masuka, Josiah Tatenda
|
|
|
|
12 |
p. 583-589
|
artikel
|
| 58 |
First reports of adverse drug reactions
|
|
|
2016
|
|
12 |
p. 530-531
|
artikel
|
| 59 |
First reports of adverse drug reactions
|
|
|
|
|
12 |
p. 541
|
artikel
|
| 60 |
First reports of adverse drug reactions
|
|
|
2017
|
|
12 |
p. 575
|
artikel
|
| 61 |
First reports of adverse drug reactions
|
|
|
2018
|
|
12 |
p. 572
|
artikel
|
| 62 |
First reports of adverse drug reactions
|
|
|
2019
|
|
12 |
p. 618
|
artikel
|
| 63 |
First reports of adverse drug reactions
|
|
|
|
|
12 |
p. 618
|
artikel
|
| 64 |
First reports of adverse drug reactions (ADRs) in recent weeks
|
|
|
|
|
12 |
p. 17-18
|
artikel
|
| 65 |
First reports of adverse drug reactions (ADRs) in recent weeks
|
|
|
2002
|
|
12 |
p. 17-18
|
artikel
|
| 66 |
First reports of adverse drug reactions (ADRs) in recent weeks
|
|
|
2001
|
|
12 |
p. 15
|
artikel
|
| 67 |
First reports of adverse drug reactions and interactions
|
|
|
|
|
12 |
p. 564
|
artikel
|
| 68 |
First reports of adverse drug reactions in recent weeks
|
|
|
2015
|
|
12 |
p. 441-442
|
artikel
|
| 69 |
First reports of serious adverse drug reactions in recent weeks
|
|
|
2014
|
|
12 |
p. 426
|
artikel
|
| 70 |
First reports of serious adverse drug reactions in recent weeks
|
|
|
2012
|
|
12 |
p. 18-19
|
artikel
|
| 71 |
Fluticasone propionate/formoterol fumarate in children aged ≥ 5 years with asthma: a profile of its use
|
Deeks, Emma D.
|
|
2019
|
|
12 |
p. 601-606
|
artikel
|
| 72 |
Fluticasone propionate/salmeterol (Wixela® Inhub®) dry-powder inhaler in asthma and COPD: a profile of its use in the USA
|
Blair, Hannah A.
|
|
2019
|
|
12 |
p. 583-591
|
artikel
|
| 73 |
Fremanezumab in the prevention of migraine: a profile of its use
|
Lamb, Yvette N.
|
|
2019
|
|
12 |
p. 592-600
|
artikel
|
| 74 |
Identify underlying cause of hirsutism and individualize treatment as required
|
|
|
2014
|
|
12 |
p. 417-421
|
artikel
|
| 75 |
Immunogenicity of biosimilars
|
Mirkov, Sanja
|
|
2016
|
|
12 |
p. 532-538
|
artikel
|
| 76 |
Inhaled glycopyrronium bromide: a guide to its use in moderate to severe chronic obstructive pulmonary disease
|
Lyseng-Williamson, Katherine A.
|
|
2013
|
|
12 |
p. 367-372
|
artikel
|
| 77 |
In patients receiving end-of-life care, medications used to treat co-morbid diseases should be discontinued when appropriate
|
|
|
2014
|
|
12 |
p. 432-434
|
artikel
|
| 78 |
Intranasal metoclopramide for acute and recurrent diabetic gastroparesis in adults
|
Singh-Franco, Devada
|
|
|
|
12 |
p. 581-589
|
artikel
|
| 79 |
Intravenous minocycline in multidrug-resistant infections: a profile of its use in the USA with a focus on Acinetobacter infections
|
Lyseng-Williamson, Katherine A.
|
|
2017
|
|
12 |
p. 555-565
|
artikel
|
| 80 |
Intravenous minocycline in multidrug-resistant infections: a profile of its use in the USA with a focus on Acinetobacter infections
|
Lyseng-Williamson, Katherine A.
|
|
|
|
12 |
p. 555-565
|
artikel
|
| 81 |
Iomeprol — a promising new nonionic contrast medium
|
|
|
2001
|
|
12 |
p. 1-4
|
artikel
|
| 82 |
Is combination treatment with a statin + a fibrate dangerous? Two case reports
|
Kannangara, Lushanthi
|
|
2017
|
|
12 |
p. 585-588
|
artikel
|
| 83 |
Knowledge and consumption of emergency contraception pills in a tertiary education student population
|
Joaquim, João
|
|
2018
|
|
12 |
p. 583-589
|
artikel
|
| 84 |
Language proficiency and warfarin-related adverse events in older immigrants and Canadian residents: a population-based cohort study
|
Wijeratne, Don Thiwanka
|
|
|
|
12 |
p. 590-598
|
artikel
|
| 85 |
Lanreotide Autogel® in acromegaly: a guide to its use in the EU
|
Scott, Lesley J.
|
|
2015
|
|
12 |
p. 409-416
|
artikel
|
| 86 |
Lesinurad in hyperuricaemia of gout: a profile of its use in the EU
|
Blair, Hannah A.
|
|
2018
|
|
12 |
p. 560-566
|
artikel
|
| 87 |
Levonorgestrel 52 mg intrauterine system (Levosert®)/Liletta®) in contraception: a profile of its use
|
Lyseng-Williamson, Katherine A.
|
|
|
|
12 |
p. 539-546
|
artikel
|
| 88 |
Lomitapide: a guide to its use in adults with homozygous familial hypercholesterolaemia in the EU
|
Lyseng-Willliamson, Katherine A.
|
|
2013
|
|
12 |
p. 373-378
|
artikel
|
| 89 |
Manage drug-induced parkinsonism through early recognition of the condition and discontinuation of the causative agent
|
|
|
2012
|
|
12 |
p. 20-23
|
artikel
|
| 90 |
Management of unclassified inflammatory bowel disease in children requires an individualized approach
|
|
|
2017
|
|
12 |
p. 571-574
|
artikel
|
| 91 |
Manage pain in paediatric oncology patients at the end of life using a multimodal interdisciplinary approach
|
|
|
2016
|
|
12 |
p. 515-520
|
artikel
|
| 92 |
Manage vitiligo with a personalised approach: consider old and new treatments
|
France, Nicole L.
|
|
|
|
12 |
p. 421-425
|
artikel
|
| 93 |
Manage vulvodynia using a multimodal and individualized approach
|
|
|
2019
|
|
12 |
p. 612-617
|
artikel
|
| 94 |
Many drugs are available for hypertension, with more in development
|
Lee, Arnold
|
|
|
|
12 |
p. 520-526
|
artikel
|
| 95 |
Miglitol: targets postprandial plasma glucose in type 2 diabetes
|
|
|
2000
|
|
12 |
p. 1-6
|
artikel
|
| 96 |
Mitotane in adrenocortical carcinoma: a profile of its use
|
Shirley, Matt
|
|
|
|
12 |
p. 508-519
|
artikel
|
| 97 |
mRNA COVID-19 vaccines are well tolerated and myopericarditis is a rare adverse event following immunisation
|
Fenton, Caroline
|
|
|
|
12 |
p. 532-540
|
artikel
|
| 98 |
Multi-pronged approach proves best for otitis externa
|
|
|
2000
|
|
12 |
p. 10-14
|
artikel
|
| 99 |
Naltrexone ER/bupropion ER in obesity management: a guide to its use
|
Greig, Sarah L.
|
|
2015
|
|
12 |
p. 417-424
|
artikel
|
| 100 |
New in the marketplace
|
|
|
2001
|
|
12 |
p. 16
|
artikel
|
| 101 |
New in the marketplace
|
|
|
2002
|
|
12 |
p. 26
|
artikel
|
| 102 |
Nirsevimab in the prevention of respiratory syncytial virus lower respiratory tract disease: a profile of its use
|
Shirley, Matt
|
|
|
|
12 |
p. 413-420
|
artikel
|
| 103 |
Nonadherence to immunosuppressive therapy is a significant problem after solid-organ transplantation
|
|
|
2002
|
|
12 |
p. 19-21
|
artikel
|
| 104 |
Opioid misuse in older patients requires careful consideration of many factors
|
Kang, Connie
|
|
|
|
12 |
p. 527-531
|
artikel
|
| 105 |
Overcome nonadherence to topical treatments in atopic dermatitis by improving trust and communication between patients and healthcare professionals
|
|
|
2017
|
|
12 |
p. 576-579
|
artikel
|
| 106 |
“Over-the-counter” cannabidiol (CBD) sold in the community pharmacy setting in Colorado
|
Shea, Leticia A.
|
|
|
|
12 |
p. 573-582
|
artikel
|
| 107 |
Patchy evidence in skin-picking disorder supports management with combined behavioural and drug treatments
|
|
|
2019
|
|
12 |
p. 607-611
|
artikel
|
| 108 |
Pharmacist perspectives towards pharmaceutical care services in neonatal intensive care units in Australia and Poland
|
Krzyżaniak, Natalia
|
|
2018
|
|
12 |
p. 573-582
|
artikel
|
| 109 |
Plecanatide in chronic idiopathic constipation and irritable bowel syndrome with constipation: a profile of its use in the USA
|
Blair, Hannah A.
|
|
2018
|
|
12 |
p. 554-559
|
artikel
|
| 110 |
Prescriber responses to alternative alert builds (AABs) designed for enduring drug shortages: a descriptive study
|
Pujol Rooks, Christine M.
|
|
|
|
12 |
p. 599-606
|
artikel
|
| 111 |
Preventative strategies may reduce the risk of chronic kidney disease in elderly patients receiving lithium
|
|
|
2015
|
|
12 |
p. 443-447
|
artikel
|
| 112 |
Preventing and managing radiodermatitis may involve a range of strategies, but conclusive evidence to support any particular intervention is lacking
|
|
|
2016
|
|
12 |
p. 521-525
|
artikel
|
| 113 |
Prolonged-release fampridine: a guide to its use in multiple sclerosis in the EU
|
Lyseng-Williamson, Katherine A.
|
|
2012
|
|
12 |
p. 1-4
|
artikel
|
| 114 |
Psychotherapy supported by drug treatment is the prescription for children and adolescents with post-traumatic stress disorder
|
|
|
2002
|
|
12 |
p. 6-9
|
artikel
|
| 115 |
Quantitative and qualitative analysis of prescriptions at a tertiary-care hospital
|
Sadhukhan, Moutusi
|
|
2015
|
|
12 |
p. 452-457
|
artikel
|
| 116 |
Relationship between timing of surgical antimicrobial prophylaxis and surgical site infection in a tertiary-care hospital
|
Khakhkhar, Tejas
|
|
2016
|
|
12 |
p. 539-544
|
artikel
|
| 117 |
Rely on clinical experience to help guide treatment selection for primary cicatricial (scarring) alopecias
|
|
|
2012
|
|
12 |
p. 15-17
|
artikel
|
| 118 |
Rimegepant orally disintegrating tablets in the acute treatment of migraine: a profile of their use
|
Kim, Esther S.
|
|
|
|
12 |
p. 547-552
|
artikel
|
| 119 |
Role of proton pump inhibitors in the prevention of NSAID-induced ulcers now emerging
|
|
|
2000
|
|
12 |
p. 6-10
|
artikel
|
| 120 |
Self-medication during Covid-19 pandemic: challenges and opportunities
|
Malik, Muna
|
|
|
|
12 |
p. 565-567
|
artikel
|
| 121 |
Severe prolonged neutropenia following administration of tocilizumab in a patient affected by COVID-19: a case report and brief review of the literature
|
Bernardo, Luca
|
|
|
|
12 |
p. 568-572
|
artikel
|
| 122 |
Somatrogon in paediatric growth hormone deficiency: a profile of its use in the EU
|
Kim, Esther S.
|
|
|
|
12 |
p. 501-507
|
artikel
|
| 123 |
Spesolimab in generalised pustular psoriasis flares: a profile of its use
|
Nie, Tina
|
|
|
|
12 |
p. 404-412
|
artikel
|
| 124 |
Standardized quality house dust mite sublingual tablets (Acarizax®): a guide to their use as sublingual allergy immunotherapy in Europe
|
Lyseng-Williamson, Katherine A.
|
|
2016
|
|
12 |
p. 502-509
|
artikel
|
| 125 |
Standardized sublingual allergen extract solution (Staloral®): a guide to its use as allergen-specific immunotherapy
|
Lyseng-Williamson, Katherine A.
|
|
2014
|
|
12 |
p. 401-410
|
artikel
|
| 126 |
Subcutaneous vedolizumab in moderately to severely active ulcerative colitis or Crohn’s disease: a profile of its use
|
Hoy, Sheridan M.
|
|
|
|
12 |
p. 563-572
|
artikel
|
| 127 |
Tagraxofusp in blastic plasmacytoid dendritic cell neoplasm: a profile of its use
|
Markham, Anthony
|
|
|
|
12 |
p. 557-562
|
artikel
|
| 128 |
Tezepelumab in severe asthma: a profile of its use
|
Syed, Yahiya Y.
|
|
|
|
12 |
p. 393-403
|
artikel
|
| 129 |
The complex phenomenon of polypharmacy in older age people of Greece: data from the new era of e-prescribing
|
Charalampopoulou, Eleni
|
|
2017
|
|
12 |
p. 580-584
|
artikel
|
| 130 |
The PHASTER Study: Economic and Organizational Impact of Subcutaneous (SC) Pertuzumab and Trastuzumab Fixed-Dose Combination (PH FDC SC) for Treatment of HER2+ Breast Cancer Patients
|
Munzone, Elisabetta
|
|
|
|
12 |
p. 432-446
|
artikel
|
| 131 |
Ticagrelor: a review of its cost effectiveness in the management of acute coronary syndromes
|
Lyseng-Williamson, Katherine A.
|
|
2013
|
|
12 |
p. 379-386
|
artikel
|
| 132 |
Tofacitinib in ulcerative colitis: a profile of its use
|
Heo, Young-A
|
|
|
|
12 |
p. 553-563
|
artikel
|
| 133 |
Treat chronic pain with appropriate non-oral formulations of opioids in patients who have difficulty swallowing
|
|
|
2017
|
|
12 |
p. 566-570
|
artikel
|
| 134 |
Treat keloids and hypertrophic scars with a combination of interventions to obtain the best results
|
|
|
2016
|
|
12 |
p. 526-529
|
artikel
|
| 135 |
Treatment options for patients with severe rheumatoid arthritis are gradually increasing
|
|
|
2001
|
|
12 |
p. 4-8
|
artikel
|
| 136 |
Understand the benefits and risks of intravenous methadone for perioperative and chronic cancer pain management
|
Nie, Tina
|
|
|
|
12 |
p. 426-431
|
artikel
|
| 137 |
Use antipyretics for at-home management of children with low-risk fever and distress
|
|
|
2014
|
|
12 |
p. 422-425
|
artikel
|
| 138 |
Use pharmacological options sparingly and cautiously in children with nocturnal enuresis
|
|
|
2012
|
|
12 |
p. 12-14
|
artikel
|
| 139 |
Vitamin D with calcium supplements: a new hope for the treatment of dengue infection
|
Islam, Muhammad Torequl
|
|
2019
|
|
12 |
p. 619-620
|
artikel
|
| 140 |
What will be the role of molnupiravir in the treatment of COVID-19 infection?
|
Vitiello, Antonio
|
|
|
|
12 |
p. 579-580
|
artikel
|
| 141 |
When is the best time for patients with irregular schedules to take agomelatine?
|
Hahn, Martina
|
|
2013
|
|
12 |
p. 398-400
|
artikel
|
| 142 |
90Y Ibritumomab Tiuxetan: profile report
|
|
|
2002
|
|
12 |
p. 4-6
|
artikel
|
Tijdschrift beschrijving